Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
J01EC03
|
| gptkbp:bioavailability |
high
|
| gptkbp:CASNumber |
94-19-9
|
| gptkbp:drugClass |
gptkb:antibiotic
|
| gptkbp:eliminationHalfLife |
10-17 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasInChIKey |
QJYQKZIEJYHFIQ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C17H19N3O3S
|
| gptkbp:hasSMILES |
CC1=CC=CC=C1N(C2=NC=NC(=O)N2)S(=O)(=O)N
|
| gptkbp:hasTherapeuticUse |
gptkb:Bacteria
|
| gptkbp:hasUNII |
2Z4KQ4F5G7
|
| https://www.w3.org/2000/01/rdf-schema#label |
CHEMBL21108
|
| gptkbp:isApprovedDrug |
true
|
| gptkbp:mechanismOfAction |
dihydropteroate synthase inhibitor
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:molecularWeight |
345.42
|
| gptkbp:proteinBinding |
high
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL21108
5327 DB01582 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:synonym |
Sulfamethoxydiazine
Sulfamethoxydiazine sodium Sulfamethoxydiazine sodium hydrate Sulfamethoxydiazine sodium salt |
| gptkbp:target |
dihydropteroate synthase
|
| gptkbp:bfsParent |
gptkb:Nisoxetine
|
| gptkbp:bfsLayer |
8
|